• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Sun Pharma > August 10, 2005

      Sun Pharma Buys Stake in Hungary Co.

      Posted AtFinancial Express

      MUMBAI, AUGUST 10 : Indian drug maker Sun Pharmaceutical Industries Ltd. said on Wednesday it had acquired a stake in ICN Company Hungary Ltd. from Valeant Pharmaceuticals International.The purchase of the raw materials and dosage form manufacturing operations in Hungary gave Sun an early opportunity to enter the European generic market, its chairman Dilip Shanghvi said in a statement.

      The terms of the deal were not disclosed.

      Valeant said in a statement posted on its Web site that it had reported the sold operations as discontinued operations earlier.

      "The sale of Hungary represents the final piece of our planned divestiture of non-core operations," Timothy Tyson, Valeant's chief executive officer, said.

      He said the divestiture of the company's remaining manufacturing facilities continued to advance and that Valeant was confident it would reduce its network to 4 manufacturing sites by the end of 2006.

      Shares of Sun, India's second-largest pharmaceutical company by market value, rose 2.5 percent to 615 rupees in the afternoon.

      ($1 = 43.5 Indian rupees)

      August 10, 2005


      Share this Article!

    Back to top^